Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
Speak Directly with Orchid Life For clinical inquiries or detailed product information , please contact Orchid Life
Now, the South African Health Products Regulatory Authority (SAHPRA) is sounding the alarm, warning the public against purchasing GLP-1 weight-loss products illegally marketed online
This dual action sets tirzepatide apart, offering the potential for even greater reductions in blood sugar levels and weight loss compared to semaglutide
Informed consent was obtained from the patients, and the study protocol was approved by the Ethics Committee of the Second Affiliated Hospital, Zhejiang University School of Medicine (Permit number: 2024-1360)
Check out our posters below and read more about this research here: Great work Brooke Smith, MS